sulforaphane has been researched along with Diabetes Mellitus in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, species, disease model, duration, SFN dosage as well as route of administration did not explain the heterogeneity among studies." | 2.72 | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. ( Du, K; Fan, Y; Li, D, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, K | 1 |
| Fan, Y | 1 |
| Li, D | 1 |
| Yamagishi, S | 1 |
| Matsui, T | 1 |
2 reviews available for sulforaphane and Diabetes Mellitus
| Article | Year |
|---|---|
Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Isothiocyanates; Lipids; Mice; Non-alcoholic Fa | 2021 |
Protective role of sulphoraphane against vascular complications in diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus; Diabetic Angiopathies; Glycation | 2016 |